In 2022, Amedisys had the opportunity to leverage advanced molecular testing technology to rapidly identify infections using technology from Patients Choice Laboratories. Today, we are the first home health system to implement it in all of our care centers nationwide. Read more in our new blog: https://hubs.li/Q02FzQGg0
The next step to better, faster patient care and outcomes.
I love the idea! WOW!
President at Patients Choice Laboratories of Indiana
1moIt is an honor to partner with Amedisys. Together, we are working to help reduce unnecessary healthcare costs by rapidly identifying infections and ensuring that each patient gets the most appropriate treatment within 24 hours.